Home > Analytics > TITAN BIOTECH

TITAN BIOTECH
Intrinsic Value | Fundamental Analysis

BOM : 524717     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Sep 28,2022
Price(EOD): ₹ 269.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Chemicals
MCap: ₹ 223.56 Cr
Value of ₹ 1 Lac invested in TITAN BIOTECH
on Sep 28,2017 (price: ₹ 61.00)

₹ 1 L

₹ 4.42 L

1W : -2.5% 1M : 9% 1Y : -15.2%
COMMUNITY POLL
for TITAN BIOTECH
Please provide your vote to see the results
TITAN BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
TITAN BIOTECH -2.5% 9% -15.2%
PIDILITE INDUSTRIES -1.4% 2.6% 14.3%
AARTI INDUSTRIES -10.9% -3.6% -12.2%
DEEPAK NITRITE -4% 6.8% -17.2%
ATUL -5.9% -2.1% -6.2%
ALKYL AMINES CHEMICALS -5.3% -4% -27.3%
TATA CHEMICALS -9% -7.5% 20.6%
NAVIN FLUORINE INTERNATIONAL -5.6% 5% 14%
GODREJ INDUSTRIES -4.8% -7.8% -24.3%

FUNDAMENTAL ANALYSIS OF TITAN BIOTECH

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF TITAN BIOTECH

 
Valuation Score
[As on : Sep 28,2022 ]

Ratio Consolidated
P/E
P/B
P/S
9.09
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 24.48 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

2.26
P/B Calculated based on Book Value of Rs 98.67 Cr
[Latest Year - Mar2022 - Consolidated Results ]

1.54
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 144.75 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF TITAN BIOTECH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
269%
129%
138%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF TITAN BIOTECH


Insights 💡 TITAN BIOTECH is one of the top 18% companies with bullish price momentum currently! Discover More →

TITAN BIOTECH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF TITAN BIOTECH

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.13
0.47
0.68
0.43
0.21
0.61
0.74
0.52
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF TITAN BIOTECH

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF TITAN BIOTECH

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
6.25%
8.68%
10.06%
12.17%
-15.55%
-44.02%
-44.07%
-41.39%
QtrlyTrend
0
Latest Qtr: Jun2022
Quarterly Result Analysis →


TITAN BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about TITAN BIOTECH


Is TITAN BIOTECH good for long term investment?

As on Sep 28,2022, the Fundamentals of TITAN BIOTECH look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TITAN BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TITAN BIOTECH UnderValued or OverValued?

As on Sep 28,2022, TITAN BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TITAN BIOTECH ?

As on Sep 28,2022, the Intrinsic Value of TITAN BIOTECH is Rs. 113.36 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 73.05
Fair Value [Median EV / Sales Model] : Rs. 117.51
Fair Value [Median Price / Sales Model] : Rs. 113.36
Estimated Median Fair Value of TITAN BIOTECH : Rs. 113.36

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is TITAN BIOTECH trading at a Premium or Discount?

As on Sep 28,2022, TITAN BIOTECH is trading at a Premium of 138% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].